Keywords: اصلاح کننده های پاسخ بیولوژیکی; Biologics; biologic response modifiers; immune dysfunction; infection; autoimmunity; immunodeficiency; BRM; Biological response modifier; CNS; Central nervous system; CTLA-4; Cytotoxic T lymphocyte-associated protein 4; IBD; Inflammatory bowel disease;